Abstract
Certain easily recognisable features are commonly seen in the bone scans of patients with metabolic bone disorders. Seven such features have been numerically graded by three independent observers in the scans of 100 patients with metabolic bone disease and of 50 control subjects. The total score for each patient is defined as the metabolic index. The mean metabolic index for each group of patients with metabolic bone disease is significantly greater than that for the control group (P<0.001).
Similar content being viewed by others
References
Fogelman, I., Bessent, R.G., Turner, J.G., Citrin, D.L., Boyle, I.T., Greig, W.R.: The use of whole body retention of 99m-Tc-Diphosphonate in the diagnosis of metabolic bone disease. J. Nucl. Med. 19, 270–275 (1978b)
Fogelman, I., McKillop, J.H., Bessent, R.G., Boyle, I.T., Turner, J.G., Greig, W.R.: The role of bone scanning in osteomalacia. J. Nucl. Med. 19, 245–248 (1978a)
Krishnamurthy, G.T., Brickman, A.S., Blahd, W.H.: Technetium-99m-Sn-pyrophosphate pharmacokinetics and bone image changes in parathyroid disease. J. Nucl. Med. 18, 236–242 (1977)
Marty, R., Denney, J.D., McKamey, M.R., Rowley, M.J.: Bone trauma and related benign disease: Assessment by bone scanning. Sem. Nucl. Med. 6, 107–120 (1976)
Olgaard, K., Heerfordt, J., Madsen, S.: Scintigraphic skeletal changes in uraemic patients on regular haemodialysis. Nephron 17, 325–334 (1976)
Sy, W.M., Mittal, A.K.: Bone scan in chronic dialysis patients with evidence of secondary hyperparathyroidism and renal osteodystrophy. Br. J. Radiol. 48, 878–884 (1975)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fogelman, I., Citrin, D.L., Turner, J.G. et al. Semi-quantitative interpretation of the bone scan in metabolic bone disease. Eur J Nucl Med 4, 287–289 (1979). https://doi.org/10.1007/BF00304886
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF00304886